InnovHeart raised €49M in a Series C round in Jan 2022. The company is based in Milano, Italy. Investors in the round: Genextra, Grand Pharma, Indaco Venture Partners and 1 other. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
